nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrazepam—CYP2E1—Dacarbazine—skin cancer	0.128	0.201	CbGbCtD
Nitrazepam—ABCB1—Vismodegib—skin cancer	0.106	0.168	CbGbCtD
Nitrazepam—CYP3A4—Imiquimod—skin cancer	0.092	0.145	CbGbCtD
Nitrazepam—CYP3A4—Temozolomide—skin cancer	0.092	0.145	CbGbCtD
Nitrazepam—CYP3A4—Vismodegib—skin cancer	0.0638	0.101	CbGbCtD
Nitrazepam—ABCB1—Dactinomycin—skin cancer	0.0559	0.0882	CbGbCtD
Nitrazepam—CYP3A4—Vemurafenib—skin cancer	0.0504	0.0795	CbGbCtD
Nitrazepam—ABCB1—Docetaxel—skin cancer	0.0289	0.0455	CbGbCtD
Nitrazepam—CYP3A4—Docetaxel—skin cancer	0.0173	0.0273	CbGbCtD
Nitrazepam—GABRQ—nerve—skin cancer	0.0104	0.0995	CbGeAlD
Nitrazepam—GABRR3—nerve—skin cancer	0.0104	0.0995	CbGeAlD
Nitrazepam—Unsteadiness—Fluorouracil—skin cancer	0.00999	0.0382	CcSEcCtD
Nitrazepam—GABRR2—nerve—skin cancer	0.009	0.0862	CbGeAlD
Nitrazepam—GABRR1—nerve—skin cancer	0.00866	0.083	CbGeAlD
Nitrazepam—Memory loss—Fluorouracil—skin cancer	0.00682	0.0261	CcSEcCtD
Nitrazepam—Pregnancy—Imiquimod—skin cancer	0.0064	0.0245	CcSEcCtD
Nitrazepam—Abnormal behaviour—Temozolomide—skin cancer	0.00584	0.0223	CcSEcCtD
Nitrazepam—Developmental delay—Fluorouracil—skin cancer	0.00527	0.0202	CcSEcCtD
Nitrazepam—Congenital anomaly—Fluorouracil—skin cancer	0.00527	0.0202	CcSEcCtD
Nitrazepam—Slurred speech—Fluorouracil—skin cancer	0.00448	0.0171	CcSEcCtD
Nitrazepam—GABRE—hair follicle—skin cancer	0.00402	0.0386	CbGeAlD
Nitrazepam—Balance disorder—Fluorouracil—skin cancer	0.00367	0.014	CcSEcCtD
Nitrazepam—GABRA3—neck—skin cancer	0.00365	0.035	CbGeAlD
Nitrazepam—GABRP—nipple—skin cancer	0.00357	0.0342	CbGeAlD
Nitrazepam—Digestion impaired—Temozolomide—skin cancer	0.00325	0.0124	CcSEcCtD
Nitrazepam—Aggression—Bleomycin—skin cancer	0.00294	0.0112	CcSEcCtD
Nitrazepam—Heartburn—Fluorouracil—skin cancer	0.00291	0.0111	CcSEcCtD
Nitrazepam—Muscle spasms—Vismodegib—skin cancer	0.0029	0.0111	CcSEcCtD
Nitrazepam—Memory impairment—Temozolomide—skin cancer	0.00277	0.0106	CcSEcCtD
Nitrazepam—GABRE—nipple—skin cancer	0.00273	0.0261	CbGeAlD
Nitrazepam—Lethargy—Imiquimod—skin cancer	0.00269	0.0103	CcSEcCtD
Nitrazepam—Irritability—Imiquimod—skin cancer	0.00252	0.00962	CcSEcCtD
Nitrazepam—GABRQ—head—skin cancer	0.00246	0.0236	CbGeAlD
Nitrazepam—GABRR3—head—skin cancer	0.00246	0.0236	CbGeAlD
Nitrazepam—Numbness—Fluorouracil—skin cancer	0.00242	0.00924	CcSEcCtD
Nitrazepam—Sensory loss—Fluorouracil—skin cancer	0.00231	0.00885	CcSEcCtD
Nitrazepam—Gait disturbance—Temozolomide—skin cancer	0.00223	0.00852	CcSEcCtD
Nitrazepam—Coordination abnormal—Temozolomide—skin cancer	0.00222	0.00847	CcSEcCtD
Nitrazepam—Dyspepsia—Vismodegib—skin cancer	0.00216	0.00827	CcSEcCtD
Nitrazepam—GABRG3—head—skin cancer	0.00216	0.0207	CbGeAlD
Nitrazepam—GABRR2—head—skin cancer	0.00213	0.0205	CbGeAlD
Nitrazepam—Gastrointestinal disorder—Vismodegib—skin cancer	0.00212	0.00811	CcSEcCtD
Nitrazepam—Fatigue—Vismodegib—skin cancer	0.00212	0.0081	CcSEcCtD
Nitrazepam—Dysarthria—Fluorouracil—skin cancer	0.00212	0.0081	CcSEcCtD
Nitrazepam—Heartburn—Docetaxel—skin cancer	0.0021	0.00804	CcSEcCtD
Nitrazepam—Constipation—Vismodegib—skin cancer	0.0021	0.00804	CcSEcCtD
Nitrazepam—GABRA4—mammalian vulva—skin cancer	0.0021	0.0201	CbGeAlD
Nitrazepam—Urinary incontinence—Temozolomide—skin cancer	0.0021	0.00803	CcSEcCtD
Nitrazepam—Depressed level of consciousness—Temozolomide—skin cancer	0.0021	0.00803	CcSEcCtD
Nitrazepam—Disorientation—Bleomycin—skin cancer	0.00209	0.008	CcSEcCtD
Nitrazepam—GABRR1—head—skin cancer	0.00205	0.0197	CbGeAlD
Nitrazepam—Mental disability—Temozolomide—skin cancer	0.00189	0.00722	CcSEcCtD
Nitrazepam—GABRP—female reproductive system—skin cancer	0.00179	0.0171	CbGeAlD
Nitrazepam—GABRD—head—skin cancer	0.00179	0.0171	CbGeAlD
Nitrazepam—Lethargy—Dactinomycin—skin cancer	0.00178	0.00681	CcSEcCtD
Nitrazepam—Asthenia—Vismodegib—skin cancer	0.00176	0.00674	CcSEcCtD
Nitrazepam—Pruritus—Vismodegib—skin cancer	0.00174	0.00665	CcSEcCtD
Nitrazepam—GABRG1—head—skin cancer	0.00172	0.0165	CbGeAlD
Nitrazepam—GABRA6—head—skin cancer	0.00171	0.0164	CbGeAlD
Nitrazepam—Diarrhoea—Vismodegib—skin cancer	0.00168	0.00643	CcSEcCtD
Nitrazepam—Amnesia—Temozolomide—skin cancer	0.00168	0.00643	CcSEcCtD
Nitrazepam—GABRB1—head—skin cancer	0.00167	0.016	CbGeAlD
Nitrazepam—GABRA5—head—skin cancer	0.00166	0.0159	CbGeAlD
Nitrazepam—GABRB3—connective tissue—skin cancer	0.00164	0.0157	CbGeAlD
Nitrazepam—Disorientation—Fluorouracil—skin cancer	0.00163	0.00622	CcSEcCtD
Nitrazepam—SCN1A—head—skin cancer	0.00161	0.0155	CbGeAlD
Nitrazepam—GABRE—mammalian vulva—skin cancer	0.00159	0.0153	CbGeAlD
Nitrazepam—Diplopia—Temozolomide—skin cancer	0.00158	0.00604	CcSEcCtD
Nitrazepam—Vomiting—Vismodegib—skin cancer	0.00156	0.00598	CcSEcCtD
Nitrazepam—Rash—Vismodegib—skin cancer	0.00155	0.00593	CcSEcCtD
Nitrazepam—Amnesia—Fluorouracil—skin cancer	0.00155	0.00592	CcSEcCtD
Nitrazepam—Dermatitis—Vismodegib—skin cancer	0.00155	0.00592	CcSEcCtD
Nitrazepam—GABRA3—head—skin cancer	0.00154	0.0148	CbGeAlD
Nitrazepam—Dysphagia—Dactinomycin—skin cancer	0.00151	0.00577	CcSEcCtD
Nitrazepam—Infection—Vemurafenib—skin cancer	0.00151	0.00577	CcSEcCtD
Nitrazepam—GABRA4—head—skin cancer	0.0015	0.0144	CbGeAlD
Nitrazepam—GABRR2—lymph node—skin cancer	0.00149	0.0143	CbGeAlD
Nitrazepam—GABRP—head—skin cancer	0.00149	0.0143	CbGeAlD
Nitrazepam—Ataxia—Temozolomide—skin cancer	0.00148	0.00568	CcSEcCtD
Nitrazepam—Lethargy—Fluorouracil—skin cancer	0.00148	0.00568	CcSEcCtD
Nitrazepam—Nausea—Vismodegib—skin cancer	0.00146	0.00558	CcSEcCtD
Nitrazepam—Agitation—Imiquimod—skin cancer	0.00146	0.00558	CcSEcCtD
Nitrazepam—Pneumonia—Bleomycin—skin cancer	0.00145	0.00555	CcSEcCtD
Nitrazepam—Malaise—Imiquimod—skin cancer	0.00143	0.00547	CcSEcCtD
Nitrazepam—Syncope—Imiquimod—skin cancer	0.00142	0.00544	CcSEcCtD
Nitrazepam—Hypotension—Vemurafenib—skin cancer	0.00142	0.00543	CcSEcCtD
Nitrazepam—Palpitations—Imiquimod—skin cancer	0.0014	0.00536	CcSEcCtD
Nitrazepam—Loss of consciousness—Imiquimod—skin cancer	0.00139	0.00533	CcSEcCtD
Nitrazepam—Muscular weakness—Temozolomide—skin cancer	0.00139	0.00532	CcSEcCtD
Nitrazepam—Irritability—Fluorouracil—skin cancer	0.00139	0.00531	CcSEcCtD
Nitrazepam—Convulsion—Imiquimod—skin cancer	0.00138	0.00526	CcSEcCtD
Nitrazepam—Ataxia—Fluorouracil—skin cancer	0.00137	0.00523	CcSEcCtD
Nitrazepam—Dysphagia—Temozolomide—skin cancer	0.00136	0.00522	CcSEcCtD
Nitrazepam—GABRE—female reproductive system—skin cancer	0.00136	0.0131	CbGeAlD
Nitrazepam—Pneumonia—Dactinomycin—skin cancer	0.00135	0.00517	CcSEcCtD
Nitrazepam—Anxiety—Imiquimod—skin cancer	0.00135	0.00515	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00131	0.00501	CcSEcCtD
Nitrazepam—Fatigue—Vemurafenib—skin cancer	0.00131	0.00501	CcSEcCtD
Nitrazepam—Constipation—Vemurafenib—skin cancer	0.0013	0.00496	CcSEcCtD
Nitrazepam—Lightheadedness—Docetaxel—skin cancer	0.00129	0.00495	CcSEcCtD
Nitrazepam—Hypoaesthesia—Bleomycin—skin cancer	0.00129	0.00493	CcSEcCtD
Nitrazepam—Infection—Imiquimod—skin cancer	0.00129	0.00492	CcSEcCtD
Nitrazepam—Muscular weakness—Fluorouracil—skin cancer	0.00128	0.00491	CcSEcCtD
Nitrazepam—Shock—Imiquimod—skin cancer	0.00127	0.00487	CcSEcCtD
Nitrazepam—GABRG2—head—skin cancer	0.00126	0.0121	CbGeAlD
Nitrazepam—GABRB2—head—skin cancer	0.00126	0.0121	CbGeAlD
Nitrazepam—Dysphagia—Fluorouracil—skin cancer	0.00126	0.00481	CcSEcCtD
Nitrazepam—Agranulocytosis—Dactinomycin—skin cancer	0.00126	0.0048	CcSEcCtD
Nitrazepam—Hyperhidrosis—Imiquimod—skin cancer	0.00125	0.00479	CcSEcCtD
Nitrazepam—Pneumonia—Temozolomide—skin cancer	0.00122	0.00468	CcSEcCtD
Nitrazepam—Paraesthesia—Imiquimod—skin cancer	0.00116	0.00445	CcSEcCtD
Nitrazepam—ABCB1—blood vessel—skin cancer	0.00116	0.0111	CbGeAlD
Nitrazepam—GABRB3—female reproductive system—skin cancer	0.00116	0.0111	CbGeAlD
Nitrazepam—Dyspnoea—Imiquimod—skin cancer	0.00115	0.00441	CcSEcCtD
Nitrazepam—Somnolence—Imiquimod—skin cancer	0.00115	0.0044	CcSEcCtD
Nitrazepam—GABRA2—head—skin cancer	0.00115	0.011	CbGeAlD
Nitrazepam—Dyspepsia—Imiquimod—skin cancer	0.00114	0.00436	CcSEcCtD
Nitrazepam—GABRE—head—skin cancer	0.00114	0.0109	CbGeAlD
Nitrazepam—Pneumonia—Fluorouracil—skin cancer	0.00113	0.00431	CcSEcCtD
Nitrazepam—Hypersensitivity—Vemurafenib—skin cancer	0.00112	0.00428	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Imiquimod—skin cancer	0.00112	0.00427	CcSEcCtD
Nitrazepam—Fatigue—Imiquimod—skin cancer	0.00112	0.00427	CcSEcCtD
Nitrazepam—GABRA1—head—skin cancer	0.00111	0.0106	CbGeAlD
Nitrazepam—Asthenia—Vemurafenib—skin cancer	0.00109	0.00417	CcSEcCtD
Nitrazepam—Hallucination—Temozolomide—skin cancer	0.00109	0.00416	CcSEcCtD
Nitrazepam—Hypoaesthesia—Temozolomide—skin cancer	0.00109	0.00416	CcSEcCtD
Nitrazepam—Pruritus—Vemurafenib—skin cancer	0.00107	0.00411	CcSEcCtD
Nitrazepam—Lethargy—Docetaxel—skin cancer	0.00107	0.0041	CcSEcCtD
Nitrazepam—Feeling abnormal—Imiquimod—skin cancer	0.00107	0.00408	CcSEcCtD
Nitrazepam—Agranulocytosis—Fluorouracil—skin cancer	0.00105	0.004	CcSEcCtD
Nitrazepam—Diarrhoea—Vemurafenib—skin cancer	0.00104	0.00397	CcSEcCtD
Nitrazepam—Malaise—Bleomycin—skin cancer	0.00102	0.00389	CcSEcCtD
Nitrazepam—Leukopenia—Bleomycin—skin cancer	0.00101	0.00386	CcSEcCtD
Nitrazepam—Dizziness—Vemurafenib—skin cancer	0.001	0.00384	CcSEcCtD
Nitrazepam—Hypoaesthesia—Fluorouracil—skin cancer	0.001	0.00383	CcSEcCtD
Nitrazepam—Ataxia—Docetaxel—skin cancer	0.000988	0.00378	CcSEcCtD
Nitrazepam—GABRB3—head—skin cancer	0.000966	0.00926	CbGeAlD
Nitrazepam—Vomiting—Vemurafenib—skin cancer	0.000966	0.00369	CcSEcCtD
Nitrazepam—Rash—Vemurafenib—skin cancer	0.000958	0.00366	CcSEcCtD
Nitrazepam—Dermatitis—Vemurafenib—skin cancer	0.000957	0.00366	CcSEcCtD
Nitrazepam—Hypersensitivity—Imiquimod—skin cancer	0.000954	0.00365	CcSEcCtD
Nitrazepam—Headache—Vemurafenib—skin cancer	0.000951	0.00364	CcSEcCtD
Nitrazepam—Malaise—Dactinomycin—skin cancer	0.000948	0.00362	CcSEcCtD
Nitrazepam—Cramp muscle—Docetaxel—skin cancer	0.000946	0.00362	CcSEcCtD
Nitrazepam—Leukopenia—Dactinomycin—skin cancer	0.000941	0.0036	CcSEcCtD
Nitrazepam—Asthenia—Imiquimod—skin cancer	0.000929	0.00355	CcSEcCtD
Nitrazepam—Confusional state—Bleomycin—skin cancer	0.000928	0.00355	CcSEcCtD
Nitrazepam—Pruritus—Imiquimod—skin cancer	0.000916	0.0035	CcSEcCtD
Nitrazepam—Infection—Bleomycin—skin cancer	0.000914	0.00349	CcSEcCtD
Nitrazepam—Dysphagia—Docetaxel—skin cancer	0.000908	0.00347	CcSEcCtD
Nitrazepam—Nausea—Vemurafenib—skin cancer	0.000902	0.00345	CcSEcCtD
Nitrazepam—Vision blurred—Temozolomide—skin cancer	0.000896	0.00343	CcSEcCtD
Nitrazepam—Tremor—Temozolomide—skin cancer	0.000891	0.00341	CcSEcCtD
Nitrazepam—Diarrhoea—Imiquimod—skin cancer	0.000886	0.00339	CcSEcCtD
Nitrazepam—Agitation—Temozolomide—skin cancer	0.000874	0.00334	CcSEcCtD
Nitrazepam—Hypotension—Bleomycin—skin cancer	0.00086	0.00329	CcSEcCtD
Nitrazepam—Malaise—Temozolomide—skin cancer	0.000858	0.00328	CcSEcCtD
Nitrazepam—Dizziness—Imiquimod—skin cancer	0.000856	0.00327	CcSEcCtD
Nitrazepam—Vertigo—Temozolomide—skin cancer	0.000854	0.00327	CcSEcCtD
Nitrazepam—Infection—Dactinomycin—skin cancer	0.000853	0.00326	CcSEcCtD
Nitrazepam—Leukopenia—Temozolomide—skin cancer	0.000851	0.00325	CcSEcCtD
Nitrazepam—Palpitations—Temozolomide—skin cancer	0.00084	0.00321	CcSEcCtD
Nitrazepam—Paraesthesia—Bleomycin—skin cancer	0.000826	0.00316	CcSEcCtD
Nitrazepam—Vision blurred—Fluorouracil—skin cancer	0.000826	0.00316	CcSEcCtD
Nitrazepam—Convulsion—Temozolomide—skin cancer	0.000824	0.00315	CcSEcCtD
Nitrazepam—Vomiting—Imiquimod—skin cancer	0.000824	0.00315	CcSEcCtD
Nitrazepam—Dyspnoea—Bleomycin—skin cancer	0.00082	0.00314	CcSEcCtD
Nitrazepam—Rash—Imiquimod—skin cancer	0.000817	0.00312	CcSEcCtD
Nitrazepam—Dermatitis—Imiquimod—skin cancer	0.000816	0.00312	CcSEcCtD
Nitrazepam—Pneumonia—Docetaxel—skin cancer	0.000814	0.00311	CcSEcCtD
Nitrazepam—Headache—Imiquimod—skin cancer	0.000811	0.0031	CcSEcCtD
Nitrazepam—Anxiety—Temozolomide—skin cancer	0.000807	0.00308	CcSEcCtD
Nitrazepam—GABRA2—lymph node—skin cancer	0.000805	0.00771	CbGeAlD
Nitrazepam—GABRE—lymph node—skin cancer	0.000798	0.00765	CbGeAlD
Nitrazepam—Jaundice—Docetaxel—skin cancer	0.000789	0.00302	CcSEcCtD
Nitrazepam—Leukopenia—Fluorouracil—skin cancer	0.000784	0.003	CcSEcCtD
Nitrazepam—Confusional state—Temozolomide—skin cancer	0.000783	0.00299	CcSEcCtD
Nitrazepam—Infection—Temozolomide—skin cancer	0.000771	0.00295	CcSEcCtD
Nitrazepam—Nausea—Imiquimod—skin cancer	0.000769	0.00294	CcSEcCtD
Nitrazepam—CYP2E1—lymphoid tissue—skin cancer	0.000763	0.00731	CbGeAlD
Nitrazepam—Convulsion—Fluorouracil—skin cancer	0.000759	0.0029	CcSEcCtD
Nitrazepam—Feeling abnormal—Bleomycin—skin cancer	0.000758	0.0029	CcSEcCtD
Nitrazepam—Agranulocytosis—Docetaxel—skin cancer	0.000755	0.00289	CcSEcCtD
Nitrazepam—Hyperhidrosis—Temozolomide—skin cancer	0.00075	0.00287	CcSEcCtD
Nitrazepam—Fatigue—Dactinomycin—skin cancer	0.00074	0.00283	CcSEcCtD
Nitrazepam—CYP2E1—female reproductive system—skin cancer	0.000736	0.00705	CbGeAlD
Nitrazepam—Hypoaesthesia—Docetaxel—skin cancer	0.000723	0.00276	CcSEcCtD
Nitrazepam—Confusional state—Fluorouracil—skin cancer	0.000721	0.00276	CcSEcCtD
Nitrazepam—Infection—Fluorouracil—skin cancer	0.00071	0.00272	CcSEcCtD
Nitrazepam—Feeling abnormal—Dactinomycin—skin cancer	0.000707	0.0027	CcSEcCtD
Nitrazepam—Paraesthesia—Temozolomide—skin cancer	0.000697	0.00266	CcSEcCtD
Nitrazepam—Dyspnoea—Temozolomide—skin cancer	0.000692	0.00265	CcSEcCtD
Nitrazepam—Somnolence—Temozolomide—skin cancer	0.00069	0.00264	CcSEcCtD
Nitrazepam—Dyspepsia—Temozolomide—skin cancer	0.000683	0.00261	CcSEcCtD
Nitrazepam—Hypersensitivity—Bleomycin—skin cancer	0.000678	0.00259	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Temozolomide—skin cancer	0.00067	0.00256	CcSEcCtD
Nitrazepam—Fatigue—Temozolomide—skin cancer	0.000669	0.00256	CcSEcCtD
Nitrazepam—Hypotension—Fluorouracil—skin cancer	0.000668	0.00255	CcSEcCtD
Nitrazepam—Constipation—Temozolomide—skin cancer	0.000664	0.00254	CcSEcCtD
Nitrazepam—Asthenia—Bleomycin—skin cancer	0.00066	0.00252	CcSEcCtD
Nitrazepam—Pruritus—Bleomycin—skin cancer	0.000651	0.00249	CcSEcCtD
Nitrazepam—Paraesthesia—Fluorouracil—skin cancer	0.000642	0.00245	CcSEcCtD
Nitrazepam—Feeling abnormal—Temozolomide—skin cancer	0.00064	0.00245	CcSEcCtD
Nitrazepam—Dyspnoea—Fluorouracil—skin cancer	0.000638	0.00244	CcSEcCtD
Nitrazepam—Somnolence—Fluorouracil—skin cancer	0.000636	0.00243	CcSEcCtD
Nitrazepam—Hypersensitivity—Dactinomycin—skin cancer	0.000632	0.00242	CcSEcCtD
Nitrazepam—Dyspepsia—Fluorouracil—skin cancer	0.00063	0.00241	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000617	0.00236	CcSEcCtD
Nitrazepam—Asthenia—Dactinomycin—skin cancer	0.000616	0.00235	CcSEcCtD
Nitrazepam—CYP2E1—head—skin cancer	0.000615	0.00589	CbGeAlD
Nitrazepam—Muscle spasms—Docetaxel—skin cancer	0.000608	0.00232	CcSEcCtD
Nitrazepam—CYP3A4—female reproductive system—skin cancer	0.000592	0.00567	CbGeAlD
Nitrazepam—Feeling abnormal—Fluorouracil—skin cancer	0.000589	0.00225	CcSEcCtD
Nitrazepam—Diarrhoea—Dactinomycin—skin cancer	0.000587	0.00224	CcSEcCtD
Nitrazepam—Vomiting—Bleomycin—skin cancer	0.000585	0.00224	CcSEcCtD
Nitrazepam—Rash—Bleomycin—skin cancer	0.00058	0.00222	CcSEcCtD
Nitrazepam—Dermatitis—Bleomycin—skin cancer	0.00058	0.00222	CcSEcCtD
Nitrazepam—Hypersensitivity—Temozolomide—skin cancer	0.000572	0.00219	CcSEcCtD
Nitrazepam—Syncope—Docetaxel—skin cancer	0.000567	0.00217	CcSEcCtD
Nitrazepam—Leukopenia—Docetaxel—skin cancer	0.000566	0.00216	CcSEcCtD
Nitrazepam—ABCB1—epithelium—skin cancer	0.000564	0.00541	CbGeAlD
Nitrazepam—Palpitations—Docetaxel—skin cancer	0.000559	0.00214	CcSEcCtD
Nitrazepam—Asthenia—Temozolomide—skin cancer	0.000557	0.00213	CcSEcCtD
Nitrazepam—Loss of consciousness—Docetaxel—skin cancer	0.000556	0.00213	CcSEcCtD
Nitrazepam—Pruritus—Temozolomide—skin cancer	0.000549	0.0021	CcSEcCtD
Nitrazepam—Convulsion—Docetaxel—skin cancer	0.000548	0.00209	CcSEcCtD
Nitrazepam—Nausea—Bleomycin—skin cancer	0.000547	0.00209	CcSEcCtD
Nitrazepam—Vomiting—Dactinomycin—skin cancer	0.000546	0.00209	CcSEcCtD
Nitrazepam—Rash—Dactinomycin—skin cancer	0.000541	0.00207	CcSEcCtD
Nitrazepam—Diarrhoea—Temozolomide—skin cancer	0.000531	0.00203	CcSEcCtD
Nitrazepam—Hypersensitivity—Fluorouracil—skin cancer	0.000527	0.00201	CcSEcCtD
Nitrazepam—Confusional state—Docetaxel—skin cancer	0.00052	0.00199	CcSEcCtD
Nitrazepam—Dizziness—Temozolomide—skin cancer	0.000513	0.00196	CcSEcCtD
Nitrazepam—Infection—Docetaxel—skin cancer	0.000513	0.00196	CcSEcCtD
Nitrazepam—Nausea—Dactinomycin—skin cancer	0.00051	0.00195	CcSEcCtD
Nitrazepam—Shock—Docetaxel—skin cancer	0.000508	0.00194	CcSEcCtD
Nitrazepam—Pruritus—Fluorouracil—skin cancer	0.000506	0.00193	CcSEcCtD
Nitrazepam—Vomiting—Temozolomide—skin cancer	0.000494	0.00189	CcSEcCtD
Nitrazepam—Rash—Temozolomide—skin cancer	0.000489	0.00187	CcSEcCtD
Nitrazepam—Diarrhoea—Fluorouracil—skin cancer	0.000489	0.00187	CcSEcCtD
Nitrazepam—ABCB1—mammalian vulva—skin cancer	0.000489	0.00469	CbGeAlD
Nitrazepam—Dermatitis—Temozolomide—skin cancer	0.000489	0.00187	CcSEcCtD
Nitrazepam—Headache—Temozolomide—skin cancer	0.000486	0.00186	CcSEcCtD
Nitrazepam—Hypotension—Docetaxel—skin cancer	0.000482	0.00184	CcSEcCtD
Nitrazepam—Dizziness—Fluorouracil—skin cancer	0.000473	0.00181	CcSEcCtD
Nitrazepam—Paraesthesia—Docetaxel—skin cancer	0.000463	0.00177	CcSEcCtD
Nitrazepam—Nausea—Temozolomide—skin cancer	0.000461	0.00176	CcSEcCtD
Nitrazepam—Dyspnoea—Docetaxel—skin cancer	0.00046	0.00176	CcSEcCtD
Nitrazepam—Somnolence—Docetaxel—skin cancer	0.000459	0.00175	CcSEcCtD
Nitrazepam—Vomiting—Fluorouracil—skin cancer	0.000455	0.00174	CcSEcCtD
Nitrazepam—Dyspepsia—Docetaxel—skin cancer	0.000454	0.00174	CcSEcCtD
Nitrazepam—Rash—Fluorouracil—skin cancer	0.000451	0.00172	CcSEcCtD
Nitrazepam—Dermatitis—Fluorouracil—skin cancer	0.00045	0.00172	CcSEcCtD
Nitrazepam—Headache—Fluorouracil—skin cancer	0.000448	0.00171	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Docetaxel—skin cancer	0.000446	0.0017	CcSEcCtD
Nitrazepam—Fatigue—Docetaxel—skin cancer	0.000445	0.0017	CcSEcCtD
Nitrazepam—Constipation—Docetaxel—skin cancer	0.000441	0.00169	CcSEcCtD
Nitrazepam—ABCB1—lymphoid tissue—skin cancer	0.000434	0.00416	CbGeAlD
Nitrazepam—Feeling abnormal—Docetaxel—skin cancer	0.000425	0.00163	CcSEcCtD
Nitrazepam—Nausea—Fluorouracil—skin cancer	0.000425	0.00162	CcSEcCtD
Nitrazepam—ABCB1—female reproductive system—skin cancer	0.000419	0.00402	CbGeAlD
Nitrazepam—Hypersensitivity—Docetaxel—skin cancer	0.00038	0.00145	CcSEcCtD
Nitrazepam—Asthenia—Docetaxel—skin cancer	0.00037	0.00142	CcSEcCtD
Nitrazepam—Pruritus—Docetaxel—skin cancer	0.000365	0.0014	CcSEcCtD
Nitrazepam—Diarrhoea—Docetaxel—skin cancer	0.000353	0.00135	CcSEcCtD
Nitrazepam—ABCB1—head—skin cancer	0.00035	0.00336	CbGeAlD
Nitrazepam—Dizziness—Docetaxel—skin cancer	0.000341	0.0013	CcSEcCtD
Nitrazepam—Vomiting—Docetaxel—skin cancer	0.000328	0.00125	CcSEcCtD
Nitrazepam—Rash—Docetaxel—skin cancer	0.000325	0.00124	CcSEcCtD
Nitrazepam—Dermatitis—Docetaxel—skin cancer	0.000325	0.00124	CcSEcCtD
Nitrazepam—Headache—Docetaxel—skin cancer	0.000323	0.00124	CcSEcCtD
Nitrazepam—Nausea—Docetaxel—skin cancer	0.000307	0.00117	CcSEcCtD
Nitrazepam—ABCB1—lymph node—skin cancer	0.000245	0.00235	CbGeAlD
